Repligen Corporation - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Repligen Corporation. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Repligen Corporation. The Group's principal activity is to develop novel therapeutics for the treatment of diseases of the central nervous system. It sell two products: Protein A, which is used in the production of monoclonal antibodies, SecreFlo(R), a synthetic form of the hormone secretin, which is used as an aid in the diagnosis of certain diseases of the pancreas and CTLA4-Ig for stem cell transportation and uridine for mitochondrial diseases. The customers of the Group include chromatography, diagnostics, biopharmaceutical companies and laboratory researchers.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report